发明名称 |
COMBINATION OF LOCAL AND SYSTEMIC IMMUNOMODULATIVE THERAPIES FOR ENHANCED TREATMENT OF CANCER |
摘要 |
<p>A method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic immunomodulatory anticancer agent. A further method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic targeted anticancer agent. The present invention is further directed to pharmaceutical compositions for treatment of cancer. The intralesional chemoablative pharmaceutical composition can comprise an IL chemoablative agent comprising primarily a halogenated xanthene.</p> |
申请公布号 |
CA2828940(A1) |
申请公布日期 |
2012.09.13 |
申请号 |
CA20122828940 |
申请日期 |
2012.03.09 |
申请人 |
PROVECTUS PHARMACEUTICALS, INC.;PFIZER INC. |
发明人 |
EAGLE, CRAIG J.;DEES, H. CRAIG;WACHTER, ERIC A.;SINGER, JAMIE |
分类号 |
A61K31/352;A61K38/19;A61K39/395;A61P35/00;C07K14/52;C07K16/28;C12P21/08 |
主分类号 |
A61K31/352 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|